When Every Sample Is A Life Trusted To Our Care: How CRL Automated Their Assay And Scale Throughput
![GettyImages-862197296-lab-team-test tube GettyImages-862197296-lab-team-test tube](https://vertassets.blob.core.windows.net/image/54df0729/54df0729-0c0b-45d0-b2b4-e60db8e02b78/375_250-gettyimages_862197296_lab_team_test_tube.jpg)
Faced with the onset of the COVID-19 pandemic in the US in February 2020, Clinical Reference Labs (CRL) realized that they had the resources and capabilities to make a difference, and set out to develop a qPCR-based SARS-CoV-2 assay that could use self-collected samples.
In just a few months, they identified saliva as their desired sample type, developed an assay, and obtained Emergency Use Authorization from the FDA.
Discover how Artel® technology played a critical role in Clinical Reference Labs' exceptionally fast development and scale-up of a saliva-based SARS-CoV-2 assay to meet the unprecedented testing need.
access the Case Study!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Hydrocarbon Online? Subscribe today.
Subscribe to Hydrocarbon Online
X
Subscribe to Hydrocarbon Online
Advanced Instruments, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more